Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?
The mammalian brain is extremely sensitive to alterations in cellular homeostasis as a result of environmental or physiological insults. In particular, hypoxic/ischemic challenges (i.e. reduced oxygen and/or glucose delivery) cause severe and detrimental alterations in brain function and can trigger neuronal cell death within minutes. Unfortunately, as we age, oxygen delivery to cells and tissues is impaired, thereby increasing the susceptibility of neurons to damage. Thus, hypoxic (neuronal) adaptation is significantly compromised during aging. Many neurological diseases, such as stroke, Alzheimer's disease (AD), Parkinson's disease and diabetes, are characterized by hypoxia, a state that is believed to only exacerbate disease progression. However, the contribution of hypoxia and hypoxia-mediated pathways to neurodegeneration remains unclear. This review discusses current evidence on the contribution of oxygen deprivation to AD, with an emphasis on hypoxia inducible transcription factor-1 (HIF-1)-mediated pathways and the association of AD with the cytoskeleton regulator cyclin-dependent kinase 5.
Ogunshola
O O
OO
Institute of Veterinary Physiology and Zurich Centre for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland. larao@access.uzh.ch
Antoniou
X
X
D000544:Alzheimer Disease / Q000209:etiology* / Q000235:genetics; D000818:Animals; D051360:Cyclin-Dependent Kinase 5 / Q000235:genetics / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000150:complications* / Q000235:genetics; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000502:physiology*; D009410:Nerve Degeneration / Q000209:etiology / Q000235:genetics*; D010101:Oxygen Consumption / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology
C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051360:Cyclin-Dependent Kinase 5